NIH-funded research R01 grant

Investigating how fibroblast-derived laminin affects the blood-brain barrier after brain hemorrhage

Official title: Fibroblast-derived laminin regulates blood-brain barrier integrity and fibroblast biology in hemorrhagic brain

Funded at University of South Florida · NIH-10892263 · Data updated 2026-11-12

This study is looking at how a protein made by certain cells helps heal the blood-brain barrier after a brain bleed, and it's aimed at finding new treatments for people who have had this type of injury.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of South Florida
NIH-funded
Lab location1 site (Tampa, United States)
Project startAugust 1, 2023
Project endJuly 31, 2028
Funding year2024
Award (this year)$479,126
NIH project number5R01NS134134-02
Project IDNIH-10892263 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who have suffered from an intracerebral hemorrhage or related brain injuries.

Less likely to help

Patients with conditions unrelated to brain hemorrhage or those who do not have a compromised blood-brain barrier may not benefit from this research.

What this research studies

This research focuses on understanding the role of fibroblast-derived laminin in repairing the blood-brain barrier (BBB) following intracerebral hemorrhage (ICH). The team will use mouse models to explore how the absence of this protein impacts BBB integrity and inflammation. They will also identify the molecular mechanisms involved in the BBB repair process and how fibroblast behavior is influenced after ICH. By examining these factors, the research aims to develop new therapeutic strategies for patients suffering from ICH.

Why it matters

Potential benefit: If successful, this research could lead to innovative treatments that improve recovery and reduce disability for patients who have experienced a brain hemorrhage.

How similar studies have gone: Previous research has shown promising results in understanding the role of various proteins in BBB repair, making this approach both relevant and potentially impactful.

Where this research is happening

  • University of South Florida
    Tampa, United States
    Active

Researchers

  • Principal investigator: Yao, Yao — University of South Florida
  • Study coordinator: Yao, Yao

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.